Pathogenic Relationships in Cystic Fibrosis and Renal Diseases: CFTR, SLC26A9 and Anoctamins
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241713278 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Karl Kunzelmann und 6 weiteren Autor:innen. Beteiligte Einrichtung: Physiological Institute, University of Regensburg, University Street 31, 93053 Regensburg, Germany. Hauptthemen laut MEDLINE: Cystic Fibrosis, Polycystic Kidney, Autosomal Dominant, Polycystic Kidney Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, DFG Transregio-SFB.
Abstract (Originalsprache)
The Cl−-transporting proteins CFTR, SLC26A9, and anoctamin (ANO1; ANO6) appear to have more in common than initially suspected, as they all participate in the pathogenic process and clinical outcomes of airway and renal diseases. In the present review, we will therefore concentrate on recent findings concerning electrolyte transport in the airways and kidneys, and the role of CFTR, SLC26A9, and the anoctamins ANO1 and ANO6. Special emphasis will be placed on cystic fibrosis and asthma, as well as renal alkalosis and polycystic kidney disease. In essence, we will summarize recent evidence indicating that CFTR is the only relevant secretory Cl− channel in airways under basal (nonstimulated) conditions and after stimulation by secretagogues. Information is provided on the expressions of ANO1 and ANO6, which are important for the correct expression and function of CFTR. In addition, there is evidence that the Cl− transporter SLC26A9 expressed in the airways may have a reabsorptive rather than a Cl−-secretory function. In the renal collecting ducts, bicarbonate secretion occurs through a synergistic action of CFTR and the Cl−/HCO3− transporter SLC26A4 (pendrin), which is probably supported by ANO1. Finally, in autosomal dominant polycystic kidney disease (ADPKD), the secretory function of CFTR in renal cyst formation may have been overestimated, whereas ANO1 and ANO6 have now been shown to be crucial in ADPKD and therefore represent new pharmacological targets for the treatment of polycystic kidney disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Physiological Institute, University of Regensburg, University Street 31, 93053 Regensburg, Germany.
- Department of Nephrology and Hypertension, Friedrich Alexander University Erlangen Nuremberg, 91054 Erlangen, Germany.
- Department of Pediatrics, University Hospital Münster, 48149 Münster, Germany.
ORCID-Profile: Karl Kunzelmann, Julien H Park
Förderung
- Deutsche Forschungsgemeinschaft
- DFG Transregio-SFB
Zitieren
APA
Kunzelmann, K., Ousingsawat, J., Kraus, A., Park, J. H., Marquardt, T., Schreiber, R., & Buchholz, B. (2023). Pathogenic Relationships in Cystic Fibrosis and Renal Diseases: CFTR, SLC26A9 and Anoctamins. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241713278
Vancouver
Kunzelmann K, Ousingsawat J, Kraus A, Park JH, Marquardt T, Schreiber R, et al. Pathogenic Relationships in Cystic Fibrosis and Renal Diseases: CFTR, SLC26A9 and Anoctamins. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241713278
BibTeX
@article{Kunzelmann2023,
author = {Kunzelmann, Karl and Ousingsawat, Jiraporn and Kraus, Andre and Park, Julien H and Marquardt, Thorsten and Schreiber, Rainer and Buchholz, Björn},
title = {Pathogenic Relationships in Cystic Fibrosis and Renal Diseases: CFTR, SLC26A9 and Anoctamins},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241713278}
}
EUVIMED